Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Second Chance at Life 
Act of 2021’’. 
SEC. 2. ABORTION PILL REVERSAL INFORMED CONSENT. 
The Public Health Service Act (42 U.S.C. 201 et 
seq.) is amended by adding at the end the following: 
‘‘TITLE XXXIV—ABORTION PILL 
REVERSAL INFORMED CONSENT 
‘‘SEC. 3401. DEFINITIONS. 
‘‘In this title: 
‘‘(1) ABORTION PROVIDER.—The term ‘abortion 
provider’ means any person licensed to perform a 
chemical abortion under applicable Federal and 
State laws. 
‘‘(2) CHEMICAL ABORTION.—The term ‘chem-
ical abortion’ means the use or prescription of an 
abortion-inducing drug dispensed with the intent to 
cause the death of the unborn child. 
‘‘(3) UNBORN CHILD.—The term ‘unborn child’ 
means a member of the species homo sapiens, at any 
stage of development prior to birth. 
VerDate Sep 11 2014 
02:45 Feb 18, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H552.IH
H552
kjohnson on DSK79L0C42PROD with BILLS
‘‘(4) WOMAN.—The term ‘woman’ means a fe-
male human being whether or not she has reached 
the age of majority. 
‘‘SEC. 3402. ABORTION PILL REVERSAL INFORMED CON-
SENT. 
‘‘(a) REQUIREMENT
OF
COMPLIANCE
BY
PRO-
VIDERS.—Effective 30 days after the date of enactment 
of the Second Chance at Life Act of 2021, any abortion 
provider in or affecting interstate or foreign commerce, 
who knowingly performs any chemical abortion, shall com-
ply with the requirements of this title. 
‘‘(b) INFORMED CONSENT.—Except in the case of a 
medical emergency described in section 3403, a chemical 
abortion involving the two drug process of dispensing 
mifepristone first and then misoprostol shall not be per-
formed or induced or attempted to be performed or in-
duced without the following: 
‘‘(1) The woman is informed, by telephone or in 
person, by the physician who is to perform the 
chemical abortion, by a referring physician, or by an 
agent of either physician at least 24 hours before 
the chemical abortion, that— 
‘‘(A) it may be possible to reverse the in-
tended effects of a mifepristone-induced chem-
VerDate Sep 11 2014 
20:18 Feb 22, 2021
Jkt 019200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H552.IH
H552
kjohnson on DSK79L0C42PROD with BILLS
ical abortion if the woman changes her mind 
but that time is of the essence; and 
‘‘(B) information on and assistance with 
reversing the effects of a mifepristone-induced 
chemical abortion is available on the website of 
the Department of Health and Human Services 
required by section 3405(b). 
‘‘(2) After the first drug involved in the two 
drug process is dispensed in a mifepristone-induced 
chemical abortion, the physician shall provide writ-
ten medical discharge instructions to the pregnant 
woman which must include the statement: 
‘‘ ‘Recent developing research has indicated that 
mifepristone alone is not always effective in ending a preg-
nancy. It may be possible to avoid, cease, or even to re-
verse the intended effects of a mifepristone-induced chem-
ical abortion if the second pill has not been taken. Please 
consult with a health care professional immediately.’. 
‘‘SEC. 3403. EXCEPTION FOR MEDICAL EMERGENCIES. 
‘‘(a) EXCEPTION.—The provisions of section 3402 
shall not apply in the case where a woman suffers from 
a physical disorder, physical injury, or physical illness that 
would, as certified by a physician, place the woman in dan-
ger of death unless an abortion is performed, including 
VerDate Sep 11 2014 
02:45 Feb 18, 2021
Jkt 019200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H552.IH
H552
kjohnson on DSK79L0C42PROD with BILLS
a life-endangering physical condition caused by or arising 
from the pregnancy itself. 
‘‘(b) CERTIFICATION.—Upon a determination by an 
abortion provider under subsection (a) that an abortion 
is necessary to save the life of a mother, such provider 
shall include in the medical file of the pregnant woman 
a truthful and accurate certification of the specific medical 
circumstances that support such determination. 
‘‘SEC. 3404. SIGN POSTING. 
‘‘(a) POSTING.—Any private office, freestanding sur-
gical outpatient clinic or other facility, or clinic in which 
chemical abortions, other than abortions necessary in the 
case of a medical emergency described in section 3403, 
are performed shall conspicuously post a sign (in a loca-
tion as described in subsection (c) so as to be clearly visi-
ble to patients) which reads: 
‘‘ ‘Research has indicated that mifepristone alone is 
not always effective in ending a pregnancy and that its 
effects can be blocked or reversed if the second pill has 
not yet been taken. If you change your mind prior to tak-
ing the second pill and desire to attempt to save your preg-
nancy, consult with a health care professional imme-
diately.’. 
‘‘(b) LETTERING; SIZE.—The sign required by sub-
section (a) shall be printed with lettering that is— 
VerDate Sep 11 2014 
02:45 Feb 18, 2021
Jkt 019200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H552.IH
H552
kjohnson on DSK79L0C42PROD with BILLS
‘‘(1) legible; and 
‘‘(2) at least three quarters of an inch boldfaced 
type. 
‘‘(c) LOCATIONS.—A facility in which chemical abor-
tions are performed that is a private office or a free-
standing surgical outpatient clinic shall post the sign re-
quired by subsection (a) in each patient waiting room and 
patient consultation room used by patients on whom chem-
ical abortions are performed. A hospital or any other facil-
ity in which chemical abortions are performed that is not 
a private office or freestanding surgical outpatient clinic 
shall post the required sign in each patient admission area 
used by patients on whom chemical abortions are per-
formed. 
‘‘SEC. 3405. PRINTED INFORMATION AND WEBSITE. 
‘‘(a) IN GENERAL.—The Secretary shall publish, in 
English and in each language which is the primary lan-
guage of 2 percent or more of the population of any State, 
and shall cause to be available on the website required by 
subsection (b), the following printed materials in such a 
way as to ensure that the information is easily comprehen-
sible: 
‘‘(1) Materials designed to inform the woman of 
the possibility of reversing the effects of a chemical 
VerDate Sep 11 2014 
02:45 Feb 18, 2021
Jkt 019200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H552.IH
H552
kjohnson on DSK79L0C42PROD with BILLS